These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 508626

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quantitative studies of splenic erythropoiesis in polycythaemia vera and myelofibrosis.
    Pettit JE, Lewis SM, Williams ED, Grafton CA, Bowring CS, Glass HI.
    Br J Haematol; 1976 Nov; 34(3):465-75. PubMed ID: 990184
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [On the existence of a myeloproliferative factor in patients with a myeloproliferative syndrome (author's transl)].
    Essers U, Nowak H.
    Blut; 1979 Aug; 39(2):107-15. PubMed ID: 289427
    [Abstract] [Full Text] [Related]

  • 5. Platelet defects in the myeloproliferative disorders.
    Inceman S, Tangün Y.
    Ann N Y Acad Sci; 1972 Oct 27; 201():251-61. PubMed ID: 4509685
    [No Abstract] [Full Text] [Related]

  • 6. Blood and neoplastic diseases. Myeloproliferative disorders.
    Lewis SM, Szur L.
    Br Med J; 1974 Nov 16; 4(5941):399-402. PubMed ID: 4425895
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The treatment of myeloproliferative syndromes].
    Maurice P.
    Schweiz Med Wochenschr; 1975 Oct 04; 105(40):1269-74. PubMed ID: 1061995
    [Abstract] [Full Text] [Related]

  • 9. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H, Clemmensen I.
    Scand J Clin Lab Invest; 1987 Sep 04; 47(5):429-33. PubMed ID: 3477850
    [Abstract] [Full Text] [Related]

  • 10. [Secondary hyperuricemia in hemoblastosis].
    Richter R, Hermanny G, Hofer E, Stobbe H.
    Dtsch Gesundheitsw; 1971 Nov 04; 26(45):2126-30. PubMed ID: 5145658
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M.
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec 04; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L.
    Scand J Haematol Suppl; 1967 Dec 04; 2():1-126. PubMed ID: 5243720
    [No Abstract] [Full Text] [Related]

  • 15. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
    Randi ML, Fabris F, Varotto L, Rossi C, Macri C, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Dec 04; 117(3):461-7. PubMed ID: 1703118
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A study of histamine in myeloproliferative disease.
    Gilbert HS, Warner RR, Wasserman LR.
    Blood; 1966 Dec 04; 28(6):795-806. PubMed ID: 5959473
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(2):241-51. PubMed ID: 5284903
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.